Vancomycin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Xellia Pharmaceuticals Usa Llc. The primary component is Vancomycin.
| Product ID | 70594-058_6509eb92-c2d2-4d5d-bd52-5878f837eb24 |
| NDC | 70594-058 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vancomycin |
| Generic Name | Vancomycin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-05-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA211962 |
| Labeler Name | Xellia Pharmaceuticals USA LLC |
| Substance Name | VANCOMYCIN |
| Active Ingredient Strength | 2 g/350mL |
| Pharm Classes | Glycopeptide Antibacterial [EPC],Glycopeptides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-05-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA211962 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-13 |
| Marketing Category | NDA |
| Application Number | NDA211962 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-13 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 25021-157 | Vancomycin | vancomycin hydrochloride |
| 25021-158 | Vancomycin | vancomycin hydrochloride |
| 70594-040 | Vancomycin | Vancomycin |
| 70594-041 | Vancomycin | Vancomycin |
| 70594-042 | Vancomycin | Vancomycin |
| 70594-043 | Vancomycin | Vancomycin |
| 70594-044 | Vancomycin | Vancomycin |
| 70594-056 | Vancomycin | Vancomycin |
| 70594-057 | Vancomycin | Vancomycin |
| 70594-058 | Vancomycin | Vancomycin |
| 51991-940 | Vancomycin Hydrochloride | Vancomycin |
| 51991-941 | Vancomycin Hydrochloride | Vancomycin |
| 68001-338 | Vancomycin Hydrochloride | Vancomycin |
| 68001-339 | Vancomycin Hydrochloride | Vancomycin |